ERLYSIGN
ErlySign develops noninvasive home-based early detection test kits for fatal diseases like Oral cancer, Uterine cancer, Prostate cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer and many more. With our next gen diagnostics solution we can identify the cancer even before a visible tumor or lesion appears.
ERLYSIGN
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Device
Founded:
2019-08-14
Address:
Nagpur, Maharashtra, India
Country:
India
Website Url:
http://www.erlysign.com
Total Employee:
1+
Status:
Active
Contact:
+91-9545718785
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Google Apps For Business
Current Employees Featured
Founder
Investors List
Uday Sodhi
Uday Sodhi investment in Seed Round - ErlySign
Rajesh Manthena
Rajesh Manthena investment in Seed Round - ErlySign
LetsVenture
LetsVenture investment in Seed Round - ErlySign
Hemanshu Jain
Hemanshu Jain investment in Pre Seed Round - ErlySign
Official Site Inspections
http://www.erlysign.com
- Host name: 23.137.66.148.host.secureserver.net
- IP address: 148.66.137.23
- Location: Singapore
- Latitude: 1.3667
- Longitude: 103.8
- Timezone: Asia/Singapore
More informations about "ErlySign"
ErlySign - Crunchbase Company Profile & Funding
ErlySign develops noninvasive home-based early detection test kits for fatal diseases like Oral cancer, Uterine cancer, Prostate cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer and …See details»
Erly Sign
What is Erly Sign. Erly Sign is an easy, accurate, affordable and painless way for early detection of Oral Cancer. How it worksSee details»
Erly Sign Company Profile 2024: Valuation, Funding & Investors
Www.erlysign.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Plot Number 41 House Number 1408/A, Darshana Society; Mouja …See details»
Erly Sign - Company Profile - Tracxn
Apr 29, 2024 Erly Sign - Online platform providing test kits for detecting oral cancer. Raised a total funding of $319K over 3 rounds from 9 investors. Valued at $2.69M. Founded by …See details»
Erly Sign
Oct 2, 2021 Nagpur-based diagnostics startup Erlysign’s first test kit, an easy and quick way to screen for oral cancer through a saliva sample, is undergoing clinical trials. Continue Reading. How Erly Sign As A Biotech Startup Is …See details»
Erly Sign
Erlysign is a non invasive early detection test kit for detecting Oral precancerous conditions at an early stage. What kind of test is it? This is a semi quantitative test in which we check for …See details»
Nagpur based startup gets approval for early cancer detection study
Apr 9, 2024 Nagpur-based biotech Startup ErlySign has announced a significant milestone in the fight against cancer with approval from the Indian regulatory agency CDSCO (Central Drugs …See details»
How Erly Sign As A Biotech Startup Is Changing The …
Dec 6, 2021 Erlysign was recently recognized by Global Health & Pharma News as the Best Early Stage Cancer Detection Startup 2021 in the Technology Awards. BARC Asia has named it Asia’s one of the most prestigious growing …See details»
ERLYSIGN gets CDSCO approval for large-scale clinical trials for …
Apr 9, 2024 New Delhi: ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian regulatory …See details»
CDSCO Granted Approval to ErlySign for Clinical Trials of Oral …
Apr 8, 2024 Nagpur-based biotech startup ErlySign achieves a significant milestone in cancer detection with approval from India's CDSCO (Central Drugs Standard Control Organisation) …See details»
ERLYSIGN Receives CDSCO Approval For Oral Cancer …
Apr 9, 2024 ErlySign, a biotech start-up headquartered in Nagpur, achieves a breakthrough in cancer detection with approval from the Indian regulatory agency CDSCO (Central Drugs Standard Control Organisation) for its active …See details»
ErlySign's Oral Cancer Detection Gets CDSCO Nod - LinkedIn
Apr 18, 2024 ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its …See details»
ErlySign gets CDSCO nod for large-scale clinical trials for oral …
Apr 8, 2024 ErlySign, a Nagpur-based biotech start-up received the approval from the Central Drugs Standard Control Organization (CDSCO) for its active salivary biomarker study …See details»
Erly Sign – Lumos Health
Description. Oral cancer is a major and growing global public health problem, and it remains a major cause of death worldwide. Currently, it is detected through a visual exam and/or with the …See details»
This diagnostics startup helps screen patients for oral cancer risk ...
Oct 2, 2021 The five-member Erlysign team has filed for Indian and US patents, and aims to have more patents by 2026. Shubhendara says the closest goal is set for 2023, By this time, …See details»
ERLYSIGN Achieves CDSCO Approval for Large-Scale Clinical Trials …
New Delhi, India - April 8th – ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian …See details»
ERLYSIGN Achieves Indian Regulatory Authority CDSCO Approval …
Apr 9, 2024 New Delhi – ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian regulatory …See details»
ErlySign Gets CDSCO Nod for Trials for Oral Cancer Detection …
Apr 9, 2024 ErlySign, a Nagpur-based biotech start-up received the approval from the Central Drugs Standard Control Organization (CDSCO) for its active salivary biomarker study …See details»
ErlySign achieves CDSCO approval for clinical trials of oral cancer ...
Apr 8, 2024 This pending patent underscores ERLYSIGN's ongoing efforts to expand its innovative contributions to cancer detection, aiming to provide cutting-edge solutions to …See details»
Erly Sign
Visit our website www.erlysign.com and register your test kit by entering the unique kit number on the package. This is just to make sure that the kit belongs to you and no mismatch could occur …See details»